Regulation of virulence factors in Bartonella henselae
汉赛巴尔通体毒力因子的调控
基本信息
- 批准号:8111405
- 负责人:
- 金额:$ 14.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-26 至 2012-01-25
- 项目状态:已结题
- 来源:
- 关键词:Angiogenic FactorAntigensBacillary AngiomatosisBacteriaBacterial AdhesinsBacterial GenesBacterial TypingBartonellaBartonella henselaeBindingBiological AssayBlood VesselsCat-Scratch DiseaseCellsClinicalDNADNA Microarray ChipDNA deliveryDataDiseaseEffector CellEndothelial CellsEnvironmentFutureGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGoalsImmunocompromised HostIndividualInfectionInfection preventionInfectious AgentLaboratoriesLesionLifeMediatingModelingOperonOrganPathogenesisPatientsPeptidesPhenotypePlayProcessProductionProteinsRecruitment ActivityRegulationRegulator GenesReportingResearchRoleSignal TransductionSurfaceSyndromeSystemSystemic infectionTestingTranscriptional RegulationType IV Secretion System PathwayUp-RegulationVascular Endothelial Growth FactorsVirulenceVirulence FactorsVisceralangiogenesisantimicrobialbasegene therapygenetic regulatory proteinin vivoknockout genemutantoverexpressionpromoterskin lesion
项目摘要
DESCRIPTION (provided by applicant): The bacterium Bartonella henselae causes a variety of disease syndromes including severe systemic infections in some patients, particularly in immunocompromised individuals. One manifestation of this emerging infectious agent is bacillary angiomatosis which is characterized by the presence of vascular proliferative lesions of the skin and visceral organs in infected patients. The goal of this project is to test the central hypothesis that B. henselae utilizes coordinate regulation of several virulence factor genes to enhance it's ability to promote angiogenesis. At least two important virulence factors have been identified in B. henselae that play a role in causing angiogenesis. The first is the virB operon that encodes a type IV secretion system that is responsible for delivery of the effector proteins that act on endothelial cells to promote their extended survival. The second is the major adhesin BadA that is on the surface of B. henselae and has been shown to be important in inducing vascular endothelial growth factor secretion in infected cells. Our preliminary data suggest that the two-component regulatory system OmpR/EnvZ of B. henselae is at least in part responsible for regulation of these genes. The following specific aims are proposed to test the hypothesis; 1) define the correlation between ompR and envZ expression and expression of the virB operon, 2) characterize the mechanism involved in ompR/envZ upregulation of virB, and 3) identify other virulence factor genes under control of ompR/envZ . These studies should help us understand how and why this bacterium causes mild disease in some patients and life-threatening infections in other patients resulting in angiogenic lesions. Furthermore, characterization of a gene regulatory system that controls bacterial virulence factors may prove to be a valuable target for antimicrobial therapy. An applied product of this project is the description of the regulatory mechanism of the virB type IV secretion system genes. Such information may prove valuable in future attempts to harness the use of this secretion system for delivery of DNA and protein to target cells for gene therapy. Narrative Project Description The bacterium Bartonella henselae causes a variety of disease syndromes including severe life-threatening infections in some patients, particularly in immunocompromised individuals. The unique aspect of this severe disease is the proliferation of blood vessels, or angiogenesis. This project seeks to better understand how the genes of this bacterium are controlled to cause this angiogenesis. Characterization of a gene regulatory system that controls bacterial virulence factors may prove to be a valuable target for antimicrobial therapy to prevent infections caused by B. henselae.
描述(由申请人提供):汉赛巴尔通体细菌可引起多种疾病综合征,包括某些患者(尤其是免疫功能低下的个体)的严重全身感染。这种新出现的感染因子的一种表现是杆菌性血管瘤病,其特征在于感染患者的皮肤和内脏器官的血管增生性病变的存在。这个项目的目标是测试中心假设,即B。henselae利用几种毒力因子基因的协调调节来增强其促进血管生成的能力。在B中至少鉴定了两个重要的毒力因子。在引起血管生成中起作用的Henselae。第一个是virB操纵子,其编码IV型分泌系统,该IV型分泌系统负责递送作用于内皮细胞以促进其延长存活的效应蛋白。第二个是位于B表面的主要粘附素BadA。Henselae,并且已经显示在感染细胞中诱导血管内皮生长因子分泌方面是重要的。我们的初步数据表明,B的双组分调节系统OmpR/EnvZ。henselae至少部分负责这些基因的调节。提出了以下具体目标来检验该假设:1)确定ompR和envZ表达与virB操纵子表达之间的相关性,2)表征ompR/envZ上调virB的机制,3)鉴定ompR/envZ控制下的其他毒力因子基因。这些研究应该有助于我们了解这种细菌如何以及为什么会在一些患者中引起轻微疾病,而在其他患者中导致危及生命的感染,从而导致血管生成病变。此外,控制细菌毒力因子的基因调控系统的表征可能被证明是抗菌治疗的有价值的靶点。本项目的一个应用成果是描述了virB IV型分泌系统基因的调控机制。这些信息可能在未来尝试利用这种分泌系统将DNA和蛋白质递送到靶细胞进行基因治疗时证明是有价值的。叙事 项目描述汉赛巴尔通体(Bartonella henselae)细菌可引起多种疾病综合征,包括某些患者的严重危及生命的感染,特别是免疫功能低下的个体。这种严重疾病的独特方面是血管增殖或血管生成。该项目旨在更好地了解这种细菌的基因是如何被控制以引起这种血管生成的。控制细菌毒力因子的基因调控系统的表征可能被证明是预防B引起的感染的抗菌治疗的有价值的靶点。亨瑟莱
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BURT E ANDERSON其他文献
BURT E ANDERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BURT E ANDERSON', 18)}}的其他基金
A novel zebrafish embryo model to define virulence factors of Bartonella henselae
一种新的斑马鱼胚胎模型来定义汉赛巴尔通体的毒力因子
- 批准号:
8911767 - 财政年份:2014
- 资助金额:
$ 14.55万 - 项目类别:
A novel zebrafish embryo model to define virulence factors of Bartonella henselae
一种新的斑马鱼胚胎模型来定义汉赛巴尔通体的毒力因子
- 批准号:
8651984 - 财政年份:2014
- 资助金额:
$ 14.55万 - 项目类别:
Regulation of virulence factors in Bartonella henselae
汉赛巴尔通体毒力因子的调控
- 批准号:
7665116 - 财政年份:2008
- 资助金额:
$ 14.55万 - 项目类别:
Regulation of virulence factors in Bartonella henselae
汉赛巴尔通体毒力因子的调控
- 批准号:
7907681 - 财政年份:2008
- 资助金额:
$ 14.55万 - 项目类别:
Regulation of virulence factors in Bartonella henselae
汉赛巴尔通体毒力因子的调控
- 批准号:
7523995 - 财政年份:2008
- 资助金额:
$ 14.55万 - 项目类别:
Regulation of virulence factors in Bartonella henselae
汉赛巴尔通体毒力因子的调控
- 批准号:
8097990 - 财政年份:2008
- 资助金额:
$ 14.55万 - 项目类别:
MOLECULAR CHARACTERIZATION OF ROCHALIMAEA ANTIGENS
Rochalimaea 抗原的分子特征
- 批准号:
2672522 - 财政年份:1995
- 资助金额:
$ 14.55万 - 项目类别:
MOLECULAR CHARACTERIZATION OF ROCHALIMAEA ANTIGENS
Rochalimaea 抗原的分子特征
- 批准号:
2075119 - 财政年份:1995
- 资助金额:
$ 14.55万 - 项目类别:
Bartonella henselae antigens of biological significance
具有生物学意义的汉赛巴尔通体抗原
- 批准号:
6868099 - 财政年份:1995
- 资助金额:
$ 14.55万 - 项目类别:
Bartonella henselae antigens of biological significance
具有生物学意义的汉赛巴尔通体抗原
- 批准号:
6627792 - 财政年份:1995
- 资助金额:
$ 14.55万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 14.55万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 14.55万 - 项目类别: